Statement Of Cash Flows [Abstract]

Gentian Diagnostics ASA - Filing #2547185

Concept 2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operating activities
15 458 NOK
13 952 NOK
Cash flows from (used in) investing activities [abstract]
Cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities
390,000 NOK
- NOK
Purchase of property, plant and equipment, classified as investing activities
955,000 NOK
8 637 NOK
Purchase of intangible assets, classified as investing activities
3 532 NOK
6 029 NOK
Cash flows from (used in) investing activities
4 877 NOK
14 666 NOK
Cash flows from (used in) financing activities [abstract]
Payments of lease liabilities, classified as financing activities
4 598 NOK
4 325 NOK
Cash flows from (used in) financing activities
4 598 NOK
4 325 NOK
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes
5 982 NOK
32 943 NOK
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
61,000 NOK
395,000 NOK
Cash and cash equivalents
87 642 NOK
81 599 NOK
114 936 NOK

Talk to a Data Expert

Have a question? We'll get back to you promptly.